What are suitable contraception methods for patients with diabetes, with and without complications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraception for Patients with Diabetes

Women with well-controlled diabetes without complications can safely use all contraceptive methods available to women without diabetes, while those with vascular complications or nephropathy should avoid combined hormonal contraceptives and use progestin-only or non-hormonal methods instead. 1, 2, 3

Key Principle: Preventing Unplanned Pregnancy is Critical

  • The risk of an unplanned pregnancy in women with diabetes outweighs the risk of any currently available contraception option, making effective contraception essential 1, 2
  • Unplanned pregnancy in women with diabetes carries significant risks of congenital malformations if glycemic control is not optimized preconception (target A1C <6.5%) 1, 4
  • All women with diabetes of childbearing potential should have family planning options reviewed at regular intervals to ensure effective contraception is maintained 1, 2

Contraception for Women WITHOUT Diabetes Complications

First-Line Recommendation: Long-Acting Reversible Contraception (LARC)

  • Long-acting reversible contraception may be ideal for women with diabetes and is the preferred option 1, 2
  • LARC methods include intrauterine devices (IUDs) and contraceptive implants, which provide highly effective contraception without requiring daily adherence 1

Combined Hormonal Contraceptives (CHCs) - Safe in Uncomplicated Diabetes

  • Combined oral contraceptives (estrogen plus progestin) are safe and effective for preconception care in women with uncomplicated diabetes 3
  • No consistent evidence shows that combined oral contraceptives significantly worsen glycemic control or accelerate microvascular complications in women with uncomplicated diabetes 3
  • Blood pressure measurement is the only essential examination before initiating combined hormonal contraceptives (can be obtained in non-clinical settings like pharmacies) 1
  • Glucose screening before contraceptive initiation is not necessary due to low prevalence of undiagnosed diabetes and minimal clinical impact of hormonal contraceptives on glucose metabolism 1

Progestin-Only Methods - Alternative Option

  • Progestin-only contraceptives represent safe alternatives with excellent metabolic and vascular safety profiles 3
  • These include progestin-only pills, depot medroxyprogesterone acetate injections, and progestin implants 3

Contraception for Women WITH Diabetes Complications

Absolute Contraindications to Combined Hormonal Contraceptives

Combined hormonal contraceptives must be avoided in the following situations: 3

  • Nephropathy with proteinuria (>190 mg/24h increases risk of hypertensive disorders; >400 mg/24h increases risk of intrauterine growth retardation) 1, 3
  • Active proliferative retinopathy 3
  • Cardiovascular disease or established atherosclerosis 1, 3
  • Multiple cardiovascular risk factors (hypertension, smoking, obesity) 3
  • Hypertension (particularly if uncontrolled or with vascular disease) 1, 3

Recommended Options for Complicated Diabetes

For women with diabetes complications, use: 3

  1. Progestin-only contraceptives (pills, injections, implants) - excellent metabolic and vascular safety profile 3
  2. Intrauterine devices (copper or levonorgestrel-releasing) - highly effective non-hormonal or progestin-only options 3, 5
  3. Barrier methods - safest but less effective, requiring consistent use 5

Special Considerations for Type 2 Diabetes

  • Exercise caution when prescribing combined hormonal contraception in type 2 diabetes due to frequent association with obesity and vascular risk factors 3
  • These comorbidities increase both thromboembolic and arterial risks with estrogen-containing contraceptives 3
  • Progestin-only or non-hormonal methods are preferred in this population 3

Postpartum Contraception

  • Contraception planning should be discussed and implemented immediately postpartum for all women with diabetes 1
  • This is critical because insulin sensitivity changes dramatically after delivery, and another pregnancy should be carefully planned 1
  • The same contraceptive recommendations apply in the postpartum period based on presence or absence of complications 1

History of Gestational Diabetes

  • Women with previous gestational diabetes can safely use low-dose combined oral contraceptives (30 mcg ethinyl estradiol with 150 mcg levonorgestrel) without deterioration of glucose metabolism 6
  • However, these women should be counseled about their increased lifetime risk of developing type 2 diabetes and the importance of effective contraception until ready for pregnancy 1

Common Pitfalls to Avoid

  • Do not delay contraception while waiting for "perfect" glycemic control - the risk of unplanned pregnancy is too high 1, 2
  • Do not prescribe combined hormonal contraceptives without assessing for diabetes complications, particularly nephropathy and retinopathy 3
  • Do not assume all women with type 2 diabetes are appropriate candidates for combined hormonal contraceptives - assess cardiovascular risk factors carefully 3
  • Do not forget to counsel about the critical importance of preconception glycemic optimization (A1C <6.5%) before discontinuing contraception 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Contraception Options for Women with Well-Controlled Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetes and oral contraception.

Best practice & research. Clinical endocrinology & metabolism, 2013

Guideline

Preconception and Antenatal Care for Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Contraception in the diabetic woman.

Clinics in perinatology, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.